Clinical features associated with linezolid resistance among multidrug resistant tuberculosis patients at a tertiary care hospital in Mumbai, India
Background: Multidrug-resistant tuberculosis (MDR-TB) is an increasing problem worldwide, and 24% occurs in India. Linezolid is associated with improved MDR-TB treatment outcomes but causes significant side-effects and drug susceptibility testing (DST) is rarely available. This study assessed whethe...
Main Authors: | J.A. Tornheim, E. Intini, A. Gupta, Z.F. Udwadia |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405579420300395 |
Similar Items
-
Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India
by: Juan Eduardo Resendiz-Galvan, et al.
Published: (2023-01-01) -
Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis
by: Taher Azimi, et al.
Published: (2022-08-01) -
Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
by: Barbara Eker, et al.
Published: (2008-11-01) -
Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
by: Amaylia Oehadian, et al.
Published: (2022-04-01) -
Drug susceptibilities of Mycobacterium tuberculosis against injectable second-line drugs from Pakistan: Analysis of multidrug-resistant and non-multidrug-resistant tuberculosis strains
by: Kauser Jabeen, et al.
Published: (2015-01-01)